4//SEC Filing
ANGIOTECH PHARMACEUTICALS INC 4
Accession 0001096481-10-000011
CIK 0001096481operating
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 8:56 PM ET
Size
6.1 KB
Accession
0001096481-10-000011
Insider Transaction Report
Form 4
Dent Jay Bernard
SVP, Finance
Transactions
- Award
Stock Option w/Tandem SAR
2010-03-08+35,000→ 295,000 totalExercise: $1.09From: 2010-04-01Exp: 2015-03-07→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The options will start to vest effective 04/01/2010 in equal installments on a monthly basis until 03/01/2014.
- [F2]Represents the number of the Company's shares into which the stock options are convertible. In the event that the Reporting Person elects to exercise the tandem SAR, the stock option will be cancelled and the Reporting Person will be entitled to receive a number of common shares with an aggregate value equal to the product of (a) the excess of the market price of a common share on the date of exercise over the exercise price of the tandem SAR, multiplied by (b) the number of tandem SARs exercised.
Documents
Issuer
ANGIOTECH PHARMACEUTICALS INC
CIK 0001096481
Entity typeoperating
Related Parties
1- filerCIK 0001096481
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 8:56 PM ET
- Size
- 6.1 KB